Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction
Clinical trial NCT04797104 · COMPLETED
Trial details
- NCT number
- NCT04797104
- Sponsor
- LIB Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2023-07-30
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.